EAM
Eventide Asset Management Portfolio holdings
AUM
$5.71B
1-Year Return
51.18%
This Quarter Return
+2.92%
1 Year Return
+51.18%
3 Year Return
+209.28%
5 Year Return
+283.63%
10 Year Return
+1,480.39%
AUM
$7.56B
AUM Growth
+$120M
(+1.6%)
Cap. Flow
+$91.7M
Cap. Flow
% of AUM
1.21%
Top 10 Holdings %
Top 10 Hldgs %
25.56%
Holding
165
New
13
Increased
52
Reduced
27
Closed
13
Top Buys
| 1 |
DICE
DICE Therapeutics, Inc. Common Stock
DICE
|
$59.2M |
| 2 |
FIVE9
FIVN
|
$46.1M |
| 3 |
Xometry
XMTR
|
$42M |
| 4 |
Global E Online
GLBE
|
$34.3M |
| 5 |
Fiverr
FVRR
|
$28.7M |
Top Sells
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$92.5M |
| 2 |
TRIL
Trillium Therapeutics Inc.
TRIL
|
$75.2M |
| 3 |
Celldex Therapeutics
CLDX
|
$53M |
| 4 |
BridgeBio Pharma
BBIO
|
$43.4M |
| 5 |
RingCentral
RNG
|
$33.8M |
Sector Composition
| 1 | Healthcare | 34.45% |
| 2 | Technology | 30.19% |
| 3 | Industrials | 13.01% |
| 4 | Consumer Discretionary | 7.21% |
| 5 | Communication Services | 4.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Garmin
GRMN
$45.7B
| $6.98M | 0.09% |
44,900
+10,700
| +31% | +$1.66M |
|
|
AQNU
127
DELISTED
Algonquin Power & Utilities Corp. Corporate Units
AQNU
| $6.82M | 0.09% |
140,800
+12,500
| +10% | +$605K |
|
128
Bolt Biotherapeutics
BOLT
$9.96M
| $6.76M | 0.09% |
26,700
| – | – |
|
129
Synovus
SNV
$7.15B
| $6.36M | 0.08% |
144,800
-75,400
| -34% | -$3.31M |
|
130
Advanced Drainage Systems
WMS
$11.5B
| $6.28M | 0.08% |
+58,078
| New | +$6.28M |
|
131
First Horizon
FHN
$11.3B
| $6.15M | 0.08% |
377,600
-393,400
| -51% | -$6.41M |
|
132
Design Therapeutics
DSGN
$367M
| $5.88M | 0.08% |
400,000
| – | – |
|
133
American Water Works
AWK
$28B
| $5.76M | 0.08% |
34,100
-14,800
| -30% | -$2.5M |
|
134
KB Home
KBH
$4.63B
| $5.52M | 0.07% |
141,700
-16,100
| -10% | -$627K |
|
135
VF Corp
VFC
$5.86B
| $5.18M | 0.07% |
77,300
-17,700
| -19% | -$1.19M |
|
136
Alexandria Real Estate Equities
ARE
$14.5B
| $5.12M | 0.07% |
26,800
| – | – |
|
137
Pharvaris
PHVS
$1.48B
| $4.23M | 0.06% |
244,925
-296,638
| -55% | -$5.12M |
|
138
Zoetis
ZTS
$67.9B
| $3.86M | 0.05% |
19,900
-12,900
| -39% | -$2.5M |
|
139
Shift4
FOUR
$6.01B
| $3.85M | 0.05% |
49,614
+3,454
| +7% | +$268K |
|
140
Lattice Semiconductor
LSCC
$9.05B
| $3.78M | 0.05% |
58,447
| – | – |
|
141
NextEra Energy, Inc.
NEE
$146B
| $3.76M | 0.05% |
+47,900
| New | +$3.76M |
|
142
Jack Henry & Associates
JKHY
$11.8B
| $3.22M | 0.04% |
19,600
| – | – |
|
143
Outset Medical
OM
$249M
| $3.18M | 0.04% |
4,294
+470
| +12% | +$349K |
|
144
Silicon Laboratories
SLAB
$4.45B
| $2.68M | 0.04% |
19,137
| – | – |
|
145
Transmedics
TMDX
$3.55B
| $2.56M | 0.03% |
77,364
| – | – |
|
146
RPM International
RPM
$16.2B
| $2.19M | 0.03% |
+28,200
| New | +$2.19M |
|
147
UiPath
PATH
$6.15B
| $2.05M | 0.03% |
+39,000
| New | +$2.05M |
|
|
ETTX
148
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
| $1.97M | 0.03% |
590,602
| – | – |
|
149
DocuSign
DOCU
$16.1B
| $1.24M | 0.02% |
4,819
| – | – |
|
150
ALX Oncology
ALXO
$65.3M
| – | – |
-439,950
| Closed | -$24.1M |
|